FDA gives nod to Alnylam's Onpattro for peripheral nerve diseaseOnpattro is the first-of-its kind targeted RNA-based therapy for peripheral nerve disease approved by the FDA. Perrigo to separate its prescription drug unitPerrigo’s plan to shed its prescription drug business is part of its plan to grow its consumer health business, the company said. Hikma launches sterile water for injection Hikma said it hopes its product launch will reduce the shortage of sterile water injection in hospitals. FDA gives Amicus OK for Galafold for Fabry disease Amicus Therapeutics' Galafold (migalastat) is the first oral medication for the treatment of adults with Fabry disease. US Bioservices to dispense Alnylam's Onpattro injection US Bioservices, a part of AmerisourceBergen will provide comprehensive specialty pharmacy services to patients who are being treated with Alnylam's Onpattro. Aralez to sell assets valued at $250M amid Chapter 11 filing Specialty pharmaceutical firm Aralez to sell assets and commence proceedings under CCAA in Canada and Chapter 11 in the United States. Regeneron and Sanofi launch Kevzara Pen for RA patients Regeneron and Sanofi's Kevzara's pre-filled pen was designed to help patients with rheumatoid arthritis who have grip and dexterity problems. Rite Aid rolls out seasonal flu shots Ahead of flu season, Rite Aid on Friday announced the availability of seasonal flu shots at more than 2,500 of its pharmacies. FDA commissioner Gottlieb touts record number of generic drug approvals in July July was a very good month for generic drug approvals, with the FDA giving its full approval for 96 drugs, and tentative approval for 30 drugs. FDA gives green light to 60 Degrees Pharmaceutical’s Arakoda for malaria prevention FDA clears Arakoda, the first drug approval for the prevention of malaria in almost two decades. First Previous 552 553 554 555 556 Next Last
